Orbia Advance Corporation Fluor & Energy Materials marked the 30th anniversary of its medical propellant brand, Zephex, with an event at its Rocksavage plant in Runcorn, United Kingdom.
After Lonza announced the collaboration with Ethris to develop spray-dried mRNA vaccines for Respiratory Disease Prevention, EPM spoke to Carsten Rudolph, co-founder, Ethris and Kim Shepard, director of advanced drug delivery at Lonza to learn more.
Aptamer Group presented new data on its Optimer therapeutic delivery vehicle for liver fibrosis at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting in New Orleans, LA (13-17 May 2025).
Sail Biomedicines’ Kerry Benenato and Rajesh Ramaswamy discuss the roles artificial intelligence (AI) can play in informing programmability, using the example of Sail’s tailored Endless RNATM (eRNATM) medicines.
Considering the overlapping needs of a drug therapy delivered via wearable injectors, each project benefits from its own specific approach. Portescap’s business development manager for medical applications, Dave Beckstoffer, explains.
Gerresheimer, innovative systems and solutions provider and global partner for the pharma, biotech and cosmetics industries, is now offering complete, silicone-oil- and PFAS-free syringe systems made of glass and cyclic olefin polymer (COP).
Berry Global Healthcare to showcase latest technologies for patient-centric solutions participation at this year’s RDD (Respiratory Drug Delivery) Europe Conference, taking place at the Estoril Congress Centre, Portugal from 6-9 May.
H&T Presspart (a division of the Heitkamp & Thumann Group) has announced the launch of Vytal, a ready-to-use (RTU) snap-fit closure solution for advanced therapeutics.
